FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND)
November 21, 2024 06:08 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US...
Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test
November 15, 2024 21:15 ET
|
Precede Biosciences, Inc.
Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic response to Lutetium-PSMABeyond Lutetium-PSMA, these results are...
Agenda Announced for 2025 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease
November 14, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association today announced the agenda including tracks and Chairs for the 2025 MDA Clinical & Scientific Conference being held...
ELISA Analyzers Market Size Forecast to Hit USD 960.7 Million by 2031, Growing at a CAGR of 5.9%| Says Transparency Market Research, Inc.
November 12, 2024 10:31 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Nov. 12, 2024 (GLOBE NEWSWIRE) -- The ELISA analyzers market was valued at US$ 574.7 million in 2022. Between 2023 and 2031,...
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
November 11, 2024 12:43 ET
|
AdipoPharma
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
October 31, 2024 15:28 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research (FSR) hosts Externally Led Patient-Focused Drug Development (EL-PFDD) meeting for Sarcoidosis
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
October 31, 2024 10:54 ET
|
Tevogen Bio Inc
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs. Tevogen’s AI...
Ardena Expands Bioanalytical Services in Europe
October 29, 2024 07:24 ET
|
Ardena Holding NV.
Ardena expands bioanalytical services in the Netherlands with a new lab in Oss and enhanced capabilities in Assen to meet rising client demand.
Multiomics Markets Report 2024-2029: Major Players, Products, Platforms, Applications, Market Dynamics, and Geographic Opportunities
October 29, 2024 06:48 ET
|
Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Multiomics Market" report has been added to ResearchAndMarkets.com's offering. The global market for multiomics is expected to grow from $2.7...
Optical Tweezers (Mechanobiology) Market Report 2024-2034 - Integration with Other Technologies like Raman Spectroscopy and Fluorescence Microscopy Presents Opportunities
October 28, 2024 05:20 ET
|
Research and Markets
Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The "Optical Tweezers (Mechanobiology) Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Optical Tweezers...